Kenya’s new pharmacy rules put medicine access under scrutiny as sector braces for stricter oversight

Regulators push tougher standards as pharmacies face fresh scrutiny

Kenya’s pharmacy sector is entering a new phase of scrutiny after the government and the Pharmacy and Poisons Board moved to tighten oversight of who can sell, dispense and supervise medicines. Recent official statements from the Ministry of Health say the reforms are part of a broader push to strengthen pharmaceutical regulation, support digital health reform and improve the quality and safety of medicines available to patients. The ministry has also tied the changes to its wider universal health coverage agenda, arguing that stronger controls are needed to reduce unsafe practice and improve accountability across the supply chain. ([health.go.ke](https://www.health.go.ke/index.php/moh-reaffirms-commitment-stronger-pharmaceutical-regulation-and-digital-health-transformation?utm_source=openai))

The latest controversy is centred on the 2026 Good Pharmacy Practice standards and related registration and licensing changes. Reporting in Kenyan media indicates that the draft rules would narrow some dispensing roles to degree-holding pharmacists, a shift that diploma holders and their representatives say could leave many outlets short-staffed and reduce access in areas already struggling with health-worker shortages. That criticism has become one of the key flashpoints in the debate because pharmacy access is not only about regulation on paper, but about whether patients can still obtain treatment quickly and legally in everyday settings. ([the-star.co.ke](https://the-star.co.ke/news/2026-09-04-new-rules-lock-out-diploma-holders-from-handling-drugs?utm_source=openai))

Access, safety and enforcement are now colliding

Officials and supporters of the reforms argue that Kenya needs tougher rules because the sector has long struggled with illegal chemists, weak enforcement and improper dispensing practices. A government advertising agency report quoted pharmacy leaders warning that unregistered outlets are common and that prescription-only medicines are sometimes sold without proper assessment or documentation. That concern has been reinforced by official and semi-official messaging from health authorities that say the new framework is intended to close loopholes, reduce cartels and make medicine supply more transparent. ([gaa.go.ke](https://gaa.go.ke/pharmacists-raise-alarm-over-growing-number-illegal-chemists?utm_source=openai))

The Ministry of Health has said the reforms are meant to improve medicine safety and support digital transformation in health services. In June 2026, the ministry reaffirmed support for stronger pharmaceutical regulation and for the Pharmacy and Poisons Board’s pursuit of WHO Maturity Level 3 status, presenting the effort as part of a bid to raise Kenya’s regulatory credibility. The board itself has also been publicly framing its work as patient protection, saying better oversight of pharmacies, medicines and professionals should improve the quality of care. ([health.go.ke](https://www.health.go.ke/index.php/moh-reaffirms-commitment-stronger-pharmaceutical-regulation-and-digital-health-transformation?utm_source=openai))

But the enforcement side of the story is what has made the issue politically and professionally sensitive. Kenyan media reports show that the latest rules have triggered protests from diploma holders in pharmacy, while officials have also announced fresh registration requirements for pharmacies and other pharmaceutical actors from July 1, 2026. Together, those moves suggest that the sector is being restructured not only through standards, but through a more active licensing regime that could determine which businesses continue operating and which professionals can legally supervise medicines. ([peopledaily.digital](https://peopledaily.digital/news/duale-reveals-crackdown-on-rented-pharmacy-licences-under-new-rules/amp?utm_source=openai))

A familiar policy tension: more control can mean better quality, but also fewer points of care

The core policy question is whether Kenya can raise standards without unintentionally shrinking access. On one hand, stricter rules can curb dangerous dispensing, reduce counterfeit or improperly handled medicines and improve patient protection. On the other, if the number of professionals allowed to operate or supervise pharmacies is narrowed too quickly, some communities may face longer distances, higher waiting times or fewer open outlets. That risk matters most outside major towns, where staffing shortages are already common and where a small chemist may be the only immediately reachable source of basic medicines. This is an inference from the enforcement and staffing concerns raised by regulators and practitioners, rather than a claim made directly in the rules themselves. ([gaa.go.ke](https://gaa.go.ke/pharmacists-raise-alarm-over-growing-number-illegal-chemists?utm_source=openai))

The policy debate is also being shaped by Kenya’s legal framework. The Pharmacy and Poisons Act gives the board authority over advertising and regulation of medicines, and recent legal and administrative disputes show that licensing decisions in the sector can have constitutional and labour implications. A 2025 judgment referenced a challenge over the board’s power to stop issuing certain licences to pharmaceutical technologists, underscoring that changes in pharmacy regulation are likely to keep ending up in court or in stakeholder negotiations. ([new.kenyalaw.org](https://new.kenyalaw.org/akn/ke/act/1956/17?utm_source=openai))

For patients, the practical issue is simple: when they need treatment, can they get it safely, affordably and close to home? For regulators, the answer may depend on whether Kenya can pair stricter licensing with enough trained staff, stronger inspection and better public communication. The current reforms appear to be aiming for that balance, but the backlash from technologists and the concern about illegal outlets show that the transition will be politically delicate. If the government succeeds, it could improve quality and trust in the pharmacy system. If it moves too fast or too narrowly, it risks turning a patient-safety reform into a new access problem. ([health.go.ke](https://www.health.go.ke/index.php/moh-reaffirms-commitment-stronger-pharmaceutical-regulation-and-digital-health-transformation?utm_source=openai))

What happens next

The immediate test will be implementation. That includes whether the board can enforce new standards consistently, whether the registration drive can separate legitimate businesses from illegal operators, and whether the sector can absorb the changes without leaving underserved counties worse off. The next few months will also show whether stakeholder objections lead to revisions, phased rollouts or additional exemptions for remote areas and lower-level facilities. ([peopledaily.digital](https://peopledaily.digital/news/duale-reveals-crackdown-on-rented-pharmacy-licences-under-new-rules/amp?utm_source=openai))

At a broader level, Kenya’s pharmacy reforms are now part of a larger health-system question: how to modernize regulation without reducing access. The answer will shape not just the business of dispensing medicines, but how ordinary Kenyans experience the health system when they walk into a chemist seeking relief, advice or an urgently needed prescription. ([health.go.ke](https://www.health.go.ke/index.php/moh-reaffirms-commitment-stronger-pharmaceutical-regulation-and-digital-health-transformation?utm_source=openai))

Sources consulted

Ministry of Health Kenya; Pharmacy and Poisons Board Kenya; Kenya Law; The Standard; People Daily; The Star; Government Advertising Agency; Kenyans.co.ke.

Sources:

• Ministry of Health Kenya
• Pharmacy and Poisons Board Kenya
• Kenya Law
• The Standard
• People Daily
• The Star
• Government Advertising Agency
• Kenyans.co.ke